Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4676
Upland Software
UPLD
$14.2M
| $43.2K | ﹤0.01% |
3,021
| – | – |
|
|
FWDI
4677
Forward Industries Inc
FWDI
$316M
| $42.6K | ﹤0.01% |
+6,441
| New | +$82.7K |
|
4678
YieldMax AAPL Option Income Strategy ETF
APLY
$117M
| $42.3K | ﹤0.01% |
+3,175
| New | +$43.4K |
|
4679
CALL
Novartis
NVS
$294B
| $41.4K | ﹤0.01% |
+300
| New | +$39.3K |
|
|
SUPX
4680
SuperX AI Technology Ltd
SUPX
$298M
| $41.3K | ﹤0.01% |
+2,634
| New | +$110K |
|
4681
Noodles & Co
NDLS
$93M
| $41.1K | ﹤0.01% |
7,271
| – | – |
|
|
CRCA
4682
ProShares Ultra CRCL
CRCA
$102M
| $40.4K | ﹤0.01% |
1,000
| – | – |
|
4683
Offerpad Solutions
OPAD
$23M
| $40.3K | ﹤0.01% |
3,335
+2,187
| +191% | +$48.4K |
|
4684
Nokia
NOK
$52.7B
| $40.2K | ﹤0.01% |
+6,218
| New | +$38.5K |
|
4685
Oppenheimer Holdings
OPY
$1.21B
| $39.8K | ﹤0.01% |
+551
| New | +$38.4K |
|
|
HURA
4686
TuHURA Biosciences
HURA
$146M
| $39.8K | ﹤0.01% |
52,615
+15,725
| +43% | +$30.1K |
|
4687
Liberty Broadband Class A
LBRDA
$5.33B
| $39.2K | ﹤0.01% |
811
+80
| +11% | +$4.14K |
|
4688
Silicon Motion
SIMO
$7.6B
| $38.8K | ﹤0.01% |
419
-1,299
| -76% | -$119K |
|
4689
Mastech Digital
MHH
$94.5M
| $38.5K | ﹤0.01% |
5,520
-23
| -0.4% | -$165 |
|
4690
Shell
SHEL
$250B
| $38.5K | ﹤0.01% |
524
-37,228
| -99% | -$2.74M |
|
4691
America Movil
AMX
$70.3B
| $37.7K | ﹤0.01% |
1,826
+228
| +14% | +$5.02K |
|
|
MRDN
4692
Meridian Holdings Inc
MRDN
$177M
| $37.5K | ﹤0.01% |
3,907
+281
| +8% | +$3.07K |
|
4693
CALL
Chegg
CHGG
$92.8M
| $37.2K | ﹤0.01% |
40,000
| – | – |
|
4694
FingerMotion
FNGR
$17.8M
| $37.1K | ﹤0.01% |
+30,200
| New | +$44.8K |
|
4695
Vertical Aerospace
EVTL
$113M
| $36.5K | ﹤0.01% |
6,843
+4,170
| +156% | +$21.1K |
|
|
TEN
4696
Tsakos Energy Navigation Ltd
TEN
$1.15B
| $36.5K | ﹤0.01% |
+1,626
| New | +$38.1K |
|
4697
Vivid Seats
SEAT
$84.4M
| $36.1K | ﹤0.01% |
5,010
+294
| +6% | +$2.89K |
|
|
SLSR
4698
Solaris Resources
SLSR
$1.36B
| $36K | ﹤0.01% |
+4,514
| New | +$31.3K |
|
4699
iShares Currency Hedged MSCI Japan ETF
HEWJ
$752M
| $35.9K | ﹤0.01% |
681
| – | – |
|
|
ZENA
4700
ZenaTech Inc
ZENA
$162M
| $35.7K | ﹤0.01% |
11,163
+7,544
| +208% | +$31.4K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.